Peter Suzdak compensation by year
Opus Genetics Summary Compensation Table · all 2 fiscal years held| Component | FY2017 | FY2018 |
|---|---|---|
| Salary | $450,000 | $419,931 |
| Bonus | $0 | $0 |
| Stock awards | $46,000 | $0 |
| Option awards | $135,743 | $167,999 |
| Non-equity incentive | $157,500 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $16,489 | $713,715 |
| Total | $805,732 | $1,301,645 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Opus Genetics, Inc. DEF 14A filed April 29, 2019, accession 0001140361-19-007856, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Opus Genetics, Inc. filed document, accession 0001140361-19-007856. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2019.
Opus Genetics’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| Peter Suzdak · this page | Former Chief Executive Officer | $1,301,645 |
| Douglas Swirsky | President and Chief Executive Officer | $1,184,354 |
| Ely Benaim | Former Chief Medical Officer | $851,361 |
| Lisa Nolan | Chief Business Officer and Corporate Secretary | $494,406 |
The full Opus Genetics compensation record
free company briefThis page is one person within Opus Genetics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Opus Genetics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Opus Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.